Your AI-Trained Oncology Knowledge Connection!

Opinion

Video

Cytopenias Following Imetelstat Treatment in Lower-Risk MDS

Author(s):

Andrew Brunner, MD,Amy DeZern, MD, MHS

An MDS specialist discusses cytopenias associated with imetelstat treatment in patients with lower-risk MDS, highlighting findings from the IMerge clinical trial.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!
Related Videos
Grzegorz S. Nowakowsi, MD, a consultant in the Division of Hematology in the Department of Internal Medicine and the Enterprise Deputy Director of Clinical Research at the Mayo Clinic Comprehensive Cancer Center
Julie M. Vose, MD, MBA
Marco Davila, MD, PhD, the senior vice president and associate director for Translational Research in the Department of Medicine, as well as the Rustum Family Endowed Chair in Translational Research at Roswell Park Comprehensive Cancer Center
Emily M. Hinchcliff, MD, MPH, an assistant professor of obstetrics and gynecology (gynecologic oncology) at the Feinberg School of Medicine at Northwestern Medicine
Yasmin Abaza, MD, assistant professor of medicine (hematology and oncology) at the Feinberg School of Medicine at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Nikolai Podoltsev, MD, PhD of Yale Cancer Center
4 experts are featured in this series.
Evangelia Vlachou, MD, postdoctoral research fellow, Departments of Medical Oncology and Urology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
Related Content
R/R DLBCL | Image Credit: © LASZLO - stock.adobe.com
March 20th 2025

FDA Grants Fast Track Designation to Azer-Cel for R/R DLBCL

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

Orca-T in Hematologic Malignancies
March 17th 2025

Orca-T Improves cGVHD-Free Survival in Advanced Hematologic Malignancies

D. Ross Camidge, MD, PhD; Chaplain Rhonda Cooper, primary chaplain, Johns Hopkins Sidney Kimmel Cancer Center
June 13th 2024

Camidge and Cooper on Finding Purpose and Embracing Nuance in Hospital Chaplaincy

Cema-Cel in R/R LBCL | Image Credit: © LASZLO – stock.adobe.com
March 11th 2025

Cema-Cel Induces CRs and Has Manageable Safety Profile in CD19 CAR T-Cell Therapy–Naive R/R LBCL

The top 5 OncLive videos of the week cover insights in TGCT, NSCLC, TNBC, AML, and MDS.
March 9th 2025

Five Under 5: Top Oncology Videos for the Week of 3/2